ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS

摘要

A compound of formula (1), wherein R1, R2, R3, R4 and R5 are independently selected from hydrogen, alkyl and aryl; and prodrugs thereof; and pharmaceutically acceptable salts thereof; and use of the compounds in therapy, particularly for treatment of a condition generally associated with abnormalities in glutamatergic transmission.